Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Patent for heart disease treatment:

This article was originally published in Clinica

Executive Summary

US firm CorMedica has received a US patent for its minimally invasive laser heart surgery technology. The patent covers the company's percutaneous transluminal endocardial revascularisation (PTER) technology which uses electromagnetic navigation and tracking technology. CR Bard has worldwide rights for PTER and recently sold its coronary catheter laboratory business, along with the CorMedica relationship, to Arterial Vascular Engineering (see Clinica No 816, p 1).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT083196

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel